Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $10.0 million.

  • Rapid Micro Biosystems' Other Operating Expenses fell 309.91% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.9 million, marking a year-over-year decrease of 236.81%. This contributed to the annual value of $41.4 million for FY2024, which is 24.2% up from last year.
  • Per Rapid Micro Biosystems' latest filing, its Other Operating Expenses stood at $10.0 million for Q3 2025, which was down 309.91% from $10.1 million recorded in Q2 2025.
  • Rapid Micro Biosystems' 5-year Other Operating Expenses high stood at $11.5 million for Q3 2022, and its period low was $8.6 million during Q2 2022.
  • Moreover, its 5-year median value for Other Operating Expenses was $10.3 million (2023), whereas its average is $10.3 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 10358.07% in 2021, then crashed by 2234.81% in 2022.
  • Rapid Micro Biosystems' Other Operating Expenses (Quarter) stood at $11.1 million in 2021, then decreased by 0.45% to $11.1 million in 2022, then fell by 12.88% to $9.7 million in 2023, then grew by 5.68% to $10.2 million in 2024, then dropped by 1.78% to $10.0 million in 2025.
  • Its Other Operating Expenses was $10.0 million in Q3 2025, compared to $10.1 million in Q2 2025 and $9.6 million in Q1 2025.